Brief: Amniotics Presents Positive Preclinical Data

Amniotics AB (publ)

20/06/2022 11:19

June 20 (Reuters) - Amniotics AB (publ)  AMNI.ST :
    * PRESENTS POSITIVE PRECLINICAL DATA ON STEM CELL TREATMENT
FOR
CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY AT ICRBE 2022
    * COO SAYS RESULTS SHOW POTENTIAL WIDE USAGES OF TISSUE
SPECIFIC/RELEVANT MESENCHYMAL STEM CELLS FROM AMNIOTIC FLUID AS
TREATMENT IN CONNECTION WITH CANCER THERAPY
    * COO SAYS RESULTS REPRESENT FURTHER VALIDATION OF AMNIOTICS
PLATFORM AND OUR THERAPEUTIC APPROACH

Source text for Eikon:  ID:nMFN55J2lx 
Further company coverage:  AMNI.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))